FDA Approved: KUVAN — Supplemental Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

FDA approved a supplemental application for KUVAN (sapropterin dihydrochloride) submitted by BioMarin, resulting in an updated labeling for the drug. The supple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphenylalaninemia
• Phenylketonuria

Drugs mentioned

• KUVAN (Sapropterin dihydrochloride)

Snippet

SUPPL AP for KUVAN (SAPROPTERIN DIHYDROCHLORIDE)